Clinical trial
Efficacy and Safety of Pactimibe in Patients With Atherosclerosis
NCT00185146 · Sankyo Pharma Gmbh, Industry · Completed
Key facts
| NCT number | NCT00185146 |
|---|---|
| Title | Efficacy and Safety of Pactimibe in Patients With Atherosclerosis |
| Official title | Effect of Pactimibe on the Progression of Atherosclerosis as Measured by 2-D and 3-D Carotid Ultrasound |
| Lead sponsor | Sankyo Pharma Gmbh, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Atherosclerosis |
| Intervention type | Drug |
| Interventions | Pactimibe |
| Enrollment | 200 |
| Start date | Sep 1, 2002 |
| Completion | Aug 1, 2005 |
| First posted | Sep 16, 2005 |
| Last update posted | Mar 28, 2007 |
| Countries | Germany |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: